T1	Treatment 15 41	cholinomimetic SDZ ENS-163
T2	Treatment 218 249	new cholinomimetic SDZ ENS-163.
T3	Treatment 308 499	oral placebo/intravenous saline, 50 mg of oral SDZ ENS-163/intravenous saline, oral placebo/0.4 mg of intravenous scopolamine, and 50 mg of oral SDZ ENS-163/0.4 mg of intravenous scopolamine.
